Skip to main content
SpringerLink
Log in

Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

P53 tumour suppressor gene expression was estimated immunohistochemically using DO-1 monoclonal antibody (recognising both wild-type and mutant p53) in 88 human renal tumours. Single strand conformation polymorphism (SSCP) analysis of possible mutations within exons 4–8 of the p53 gene was performed in 29 of the tumours (mostly immunostaining-positive cases). Obviously elevated p53 content was detected with DO-1 antibody in chromophobic cell carcinomas and most clear/chromophilic cell tumours (in chromophilic cell populations). In contrast, clear cell carcinomas demonstrated either complete absence of p53 expression or the presence of single immunopositive nuclei. Oncocytomas were completely negative. Additional immunostaining of the positive samples with mutant p53-specific Pab240 monoclonal antibody failed to detect immunopositive material. No p53 mutation was found in any of the samples analysed by SSCP. Our results suggest that the elevated p53 content in human renal cell carcinomas does not result from gene mutation and that p53 gene alterations are probably not an important mechanism in the development of human renal cell carcinomas. Accumulation of the wild-type p53 protein may be a useful prognostic marker indicating neoplastic progression and malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahn YS, Zerban H, Grobholz R, Bannasch P (1992) Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis 13:2329–2334

    Google Scholar 

  2. Ali IU, Schweitzer JB, Ikejiri B, Saxena A, Robertson JT, Oldfield EH (1994) Heterogeneity of subcellular localization of p53 protein in human glioblastomas. Cancer Res 54:1–5

    Google Scholar 

  3. Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM (1992) Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 52:348–356

    Google Scholar 

  4. Bannasch P, Zerban H (1990) Animal models and renal carcinogenesis. In: Eble JN (ed) Tumors and tumor-like conditions of the kidneys and ureters. Churchill Livingstone, New York, pp 1–34

    Google Scholar 

  5. Baretton G, Kuhlmann B, Krech R, Löhrs U (1991) Intratumoural heterogeneity of nuclear DNA-content and proliferation in clear cell type carcinomas of the kidney. Virchows Arch [B] 61:57–63

    Google Scholar 

  6. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP, Harris CC (1991) Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6:1779–1784

    Google Scholar 

  7. Chen C-Y, Oliner JD, Zhan Q, Fornace AJ, Vogelstein B, Kastan MB (1994) Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 91:2684–2688

    Google Scholar 

  8. Delahunt B, Nacey JN (1987) Renal cell carcinoma. II. Histological indicators of prognosis. Pathology 19:258–263

    Google Scholar 

  9. Donehower LA, Bradley A (1993) The tumor suppressor p53. Biochim Biophys Acta 1155:181–205

    Google Scholar 

  10. Finlay CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hcs 70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539

    Google Scholar 

  11. Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307–318

    Google Scholar 

  12. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663

    Google Scholar 

  13. Gannon JV, Greaves R, Iggo R, Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595–1602

    Google Scholar 

  14. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ (1993) Stage I renal cell carcinoma: a clinicopathologic study of 82 cases. Am J Surg Pathol 17:275–286

    Google Scholar 

  15. Hall PA, Lane DG (1994) p53 in tumor pathology: can we trust immunohistochemistry? J Pathol (Lond) 172:1–4

    Google Scholar 

  16. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53

    Google Scholar 

  17. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335:675–679

    Google Scholar 

  18. Imai S, Kiyozuka Y, Nishimura H, Iwanaga S, Murakami F, Imamura K, Noda T, Haga S, Yakushiji M (1994) Overexpression of the tumor suppressor gene p53 in human ovarian tumor tissues and its correlation with clinical stage. Int J Oncol 4:1097–1103

    Google Scholar 

  19. Kikuchi Y, Kishi T, Suzuki M, Furusato M, Aizawa S (1994) Polymerase chain reaction — single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas. Virchows Arch 424:229–233

    Google Scholar 

  20. Kovacs G (1993) Molecular differential pathology of renal cell tumors. Histopathology 22:1–8

    Google Scholar 

  21. Kovacs A, Störkel S, Thoenes W, Kovacs G (1992) Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol (Lond) 167:273–277

    Google Scholar 

  22. Kress S, Jahn U-R, Buchmann A, Bannasch P, Schwarz M (1992) p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 52:3220–3223

    Google Scholar 

  23. Kress S, König J, Schweizer J, Löhrke H, Bauer-Hoffman R, Schwarz M (1992) p53 mutations are absent from carcinogeninduced mouse liver tumors but occur in cell lines established from these tumors. Mol Carcinog 6:148–158

    Google Scholar 

  24. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D (1994) The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409–416

    Google Scholar 

  25. Makos M, Nelkin BD, Reiter ER, Gnarra JR, Brooks J, Isaaks W, Linehan M, Baylin SB (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53:2719–2722

    Google Scholar 

  26. Maruyama K, Shiozaki H, Shimaya K, Inoue M, Iwazawa T, Matsui S, Mori T (1994) p53 expression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 4:1061–1065

    Google Scholar 

  27. Mayall FG, Goddard H, Gibbs AR (1992) p53 immunostaining in the distinction between benign and malignant mesothelial proliferation using formalin-fixed paraffin sections. J Pathol (Lond) 168:377–381

    Google Scholar 

  28. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245

    Google Scholar 

  29. Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O (1992) Allelic losses of chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 52:1881–1885

    Google Scholar 

  30. Oka K, Ishikawa J, Bruner JM, Takahashi R, Saya H (1991) Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction. Mol Carcinog 4:10–13

    Google Scholar 

  31. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80–83

    Google Scholar 

  32. Oren M (1992) p53: the ultimate tumor suppressor gene? FASEB J 6:3169–3176

    Google Scholar 

  33. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879

    Google Scholar 

  34. Ortmann M, Vierbuchen M, Koller G, Fischer R (1988) Renal oncocytoma. I. Cytochrome C oxidase in normal and neoplastic renal tissue as detected by immunohistochemistry — a valuable aid to distinguish oncocytoma from renal cell carcinoma. Virchows Arch [B] 56:165–173

    Google Scholar 

  35. Pavelic ZP, Gluckman JL, Gapany M, Reising J, Craven JM, Kelley D, Pavelich L, Gapany S, Biddinger P, Stambrook PJ (1992) Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res 12:1389–1394

    Google Scholar 

  36. Presti JC, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC (1991) Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51:1544–1552

    Google Scholar 

  37. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM (1993) Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53:3092–3097

    Google Scholar 

  38. Rubio M-P, Deimling A von, Yandell DW, Wiestler OD, Gusella JF, Louis DN (1993) Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53:3465–3467

    Google Scholar 

  39. Schneider J, Rubio MP, Rodriguez-Escudero FJ, Seizinger BR, Castresana JS (1994) Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry. Eur J Cancer 30A:504–508

    Google Scholar 

  40. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741–748

    Google Scholar 

  41. Soini Y, Turpeeniemi-Hujanen T, Kamel D, Autio-Harmainen H, Risteli J, Risteli L, Nuorva K, Pääkkö P, Vähäkangas K (1993) p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 68:1029–1035

    Google Scholar 

  42. Steinberg P, Störkel S, Oesch F, Thoenes W (1992) Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 67:506–511

    Google Scholar 

  43. Störkel S (1993) Karzinome und Onkozytome der Niere. Fischer, Stuttgart

    Google Scholar 

  44. Suzuki Y, Tamura G, Satodate R, Fujioka T (1993) Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction — single stranded conformation polymorphism analysis. Jpn J Cancer Res 83:233–235

    Google Scholar 

  45. Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143

    Google Scholar 

  46. Tominaga O, Hamelin R, Trouvat V, Salmon RJ, Lesec G, Thomas G, Remvikos Y (1993) Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene 8:2653–2658

    Google Scholar 

  47. Uhlman DL, Nguyen PL, Manivel JC, Aeppli D, Resnick JM, Fraley EE, Zhang G, Niehans GA (1994) Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 86:1470–1475

    Google Scholar 

  48. Van den Berg FM, Tigges AJ, Schipper MEI, den Harton-Jager FCA, Kroes WGM, Walboomers JMM (1989) Expression of the nuclear oncogene p53 in colon tumors. J Pathol (Lond) 157:193–199

    Google Scholar 

  49. Van den Berg E, Van der Hout AH, Oosterhuis JW, Störkel S, Dijkhuizen T, Dam A, Zweers HMM, Mensink HJA, Buys CHCM, de Jong B (1993) Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer 55:223–227

    Google Scholar 

  50. Vogelstein B, Kinzler KW (1992) p53 finction and dysfunction. Cell 70:523–526

    Google Scholar 

  51. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T (1993) p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68:1134–1139

    Google Scholar 

  52. Yonemura Y, Fushida S, Tsugawa K, Ninomiya I, Fonseca L, Yamaguchi A, Miyazaki I, Urano T, Shiku H (1993) Correlation of p53 expression and proliferative activity in gastric cancer. Anal Cell Pathol 5:277–288

    Google Scholar 

  53. Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721–727

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Cytopathologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    G. Chemeris, A. Rempel & P. Bannasch

  2. Abteilung für Cytopathologie and Projektgruppe Tumorpromotion in der Leber, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    A. Loktinov

  3. Projektgruppe Tumorpromotion in der Leber, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    M. Schwarz

Authors
  1. G. Chemeris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Rempel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Bannasch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Loktinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chemeris, G., Rempel, A., Bannasch, P. et al. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Vichows Archiv A Pathol Anat 426, 563–569 (1995). https://doi.org/10.1007/BF00192110

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00192110

Key words

Search

Navigation